Clinical Trial Update: Association Between Genetic Polymorphism of Beta-adrenergic Receptor and Effects of Bisoprolol in Korean Heart Failure Patients. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial in Korean patients with chronic heart failure examined whether beta-adrenergic receptor genetic polymorphisms influence the effects of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Bisoprolol (Bisoprolol)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Chronic Heart Failure | Phase 4 | Status: COMPLETED | Results posted: 2012-04-10